ABSTRACT
Trade name: Erbitux (Bristol-Myers Squibb) Indications: Metastatic colorectal cancer Category: Antineoplastic; Monoclonal antibody Half-life: 75-188 hours Clinically important, potentially hazardous interactions with: None
- Journals
- Corporate
- Help & Contact
Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG© 2024 Informa UK Limited